High-Purity p-Nitro-o-Anisidine for Pharmaceutical Intermediates from Japan
High-purity p-nitro-o-anisidine (99.5%) for pharmaceutical synthesis is classified under HTS 2922.29.81.10 as a pure oxygen-function amino-phenol ether. Its nitro and methoxy groups enable reduction to key drug scaffolds.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain DMF or equivalent for pharma imports; cross-check with FDA chemical database
• Ensure <10 ppm heavy metals per USP standards to avoid Chapter 28 inorganic classification